Friday 10 February | |
Ince Group PLC | Full Year Results (TBC) |
Lancashire Holdings Ltd | Full Year Results |
S&U PLC | Trading Statement |
Victrex PLC | Trading Statement |
Monday 13 February | |
no events scheduled | |
Tuesday 14 February | |
Carr's Group PLC | Full Year Results |
Coca-Cola HBC AG | Full Year Results |
Plus500 Ltd | Full Year Results |
Tui AG | Q1 Results |
UP Global Sourcing Holdings PLC | Trading Statement |
Wednesday 15 February | |
Barclays PLC | Full Year Results |
Brunner Investment Trust PLC | Full Year Results |
Dunelm Group PLC | Half Year Results |
Equipmake Holdings PLC | Half Year Results |
Glencore PLC | Full Year Results |
Hargreaves Lansdown PLC | Half Year Results |
Pan African Resources PLC | Half Year Results |
Thursday 16 February | |
Centrica PLC | Full Year Results |
Coca-Cola Europacific Partners PLC | Full Year Results |
Indivior PLC | Full Year Results |
MJ Gleeson PLC | Half Year Results |
Moneysupermarket.com Group PLC | Full Year Results |
Relx PLC | Full Year Results |
Riverstone Credit Opportunities Income PLC | Full Year Results |
South32 Ltd | Half Year Results |
Standard Chartered PLC | Full Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
IN BRIEF: Indivior settles patent infringement case with DRL
Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Enters into a settlement agreement with Indian pharmaceutical company Dr Reddy's Laboratories Ltd and its subsidiaries together with Aquestive Therapeutics Inc. Explains that the settlement is for a patent infringement case regarding DRL's generic buprenorphine and naloxone sublingual film that is equivalent to its Suboxone sublingual film.
Read more